UK waiting time targets in lung cancer treatment: are they achievable? Results of a prospective tracking study by Devbhandari, Mohan P et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Journal of Cardiothoracic Surgery
Open Access Research article
UK waiting time targets in lung cancer treatment: are they 
achievable? Results of a prospective tracking study
Mohan P Devbhandari*1, Sing Yang Soon1, Pauline Quennell2, 
Philip Barber3, Piotr Krysiak1, Rajesh Shah1 and Mark T Jones1
Address: 1Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester, UK, 2Department of Clinical Audits, Wythenshawe 
Hospital, Manchester, UK and 3Department of Respiratory Medicine, Wythenshawe Hospital, Manchester, UK
Email: Mohan P Devbhandari* - mohandev@hotmail.com; Sing Yang Soon - SingYang.Soon@smuht.nwest.nhs.uk; 
Pauline Quennell - Pauline.Quennell@smuht.nwest.nhs.uk; Philip Barber - Phil.Barber@smuht.nwest.nhs.uk; 
Piotr Krysiak - Piotr.Krysiak@smuht.nwest.nhs.uk; Rajesh Shah - Rajesh.Shah@smuht.nwest.nhs.uk; 
Mark T Jones - Mark.Jones@smuht.nwest.nhs.uk
* Corresponding author    
Abstract
Background: Recent guidelines have specified a number of waiting time targets to prevent delay
in the treatment of lung cancer. This study was carried out to assess the quality of lung cancer
services and compare with national recommendations.
Methods: All newly diagnosed cases of lung cancer presenting to our institution via general
practitioner referral were entered into a prospective tracking study by a dedicated audit officer.
From September 2003 to March 2005 a total of 247 patients were entered into the study. Of these
133 (54%) were referred by general practitioners and the remainder 114 (46%) were internal
referrals. The Cancer Plan waiting time targets are mainly applicable to GP referrals, which formed
the study group.
Results: All the patients were seen in chest out-patients clinic within the recommended two
weeks period. However there was a delay in starting all forms of treatment. The median waiting
time to any form of treatment was 60 days (recommendation 62 days for all patients).
Conclusion: This data demonstrates that although patients receive out patient consultation in the
recommended time period, the National Cancer Plan 62 days GP referral to treatment target is
not being achieved. A concerted effort by all clinicians is required to meet the prescribed target
times.
Background
The prognosis for lung cancer remains poor with overall
five-year survival of 5–10%. This has changed little in the
past two decades [1] and is attributed to delays in presen-
tation, diagnosis, staging and treatment. Among the rec-
ommendations of the UK (United Kingdom) National
Cancer Plan has been the introduction of multi-discipli-
nary team meetings and an interval of 14 days from urgent
GP (general practitioner) referral to first outpatient assess-
ment, and 62 days from GP referral to first mode of treat-
ment [2,3]. Prospective tracking studies was designed with
the objective of monitoring the waiting times to treatment
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for lung cancer at South Manchester University Hospital
(SMUHT) and compare it with the national recommenda-
tions. SMUHT is a major UK teaching hospital receiving
secondary and tertiary referral for thoracic oncology serv-
ices which has all on site facilities for lung cancer diagno-
sis and treatment.
Materials & methods
From September 2003 to August 2004 all suspected pri-
mary lung cancer referrals to the chest clinic at our institu-
tion were tracked prospectively by a dedicated researcher
(Pauline Quennell) to identify patients with newly diag-
nosed lung cancer. Additional methods were used to cap-
ture patients who presented directly to casualty or by
internal referral from other departments which included
regular interval screenings of histology results, chest radi-
ology reports, International code of diseases codes, tho-
racic surgery database and Macmillan referrals. Patients
presenting from areas outside the primary catchment area
were excluded from the study.
At our institution all the referrals are first assessed by res-
piratory physicians in out patient's clinic or in the ward.
Following the diagnostic work up including chest x ray,
bronchoscopy, lung function tests, CT scan ± needle
biopsy, the patients are discussed in the multi disciplinary
team meetings. Increasing number of patients are having
PET scans as a part of their investigation. Following dis-
cussion at the multi-disciplinary team meeting (MDT) a
treatment plan is formulated and appropriate specialist
referrals are made. Those patients who need further inves-
tigations such as exercise test, angiogram, bone scan,
echocardiography etc. to assess the suitability for radical
treatment are re-discussed in the MDT in the light of the
new results and followed by formulation of treatment
plan and appropriate specialist referrals.
The NHS Cancer Plan waiting time targets [2] are mainly
applicable to GP referrals, which formed the study group
for this paper. Waiting times to treatments were calculated
as median days (inter quartile range) in accordance with
the National Cancer Plan guideline. Urgent GP referral to
date first seen in out patients was calculated by subtracting
date of receipt of urgent referral from the date first seen in
chest out patients clinic. Similarly urgent GP referral to
date of first definitive treatment was calculated by sub-
tracting date of receipt of urgent GP referral from the date
of commencement first definitive treatment (any of the
three modalities). Chest out patient to surgery intervals
was calculated by subtracting date of surgery from the date
of out patient consultation. Oncology referral intervals
were calculated from the MDT decision for referral to the
date of actual start of treatment.
Patients in whom tissue diagnosis was achieved success-
fully by first Invasive diagnostic method and did not
require any extra work up for commencement of treat-
ment were termed simple pathway patients. In contrast to
this those patients who required more than one methods
or attempts at tissue diagnosis or those who required
additional investigations apart from diagnostic and stag-
ing work up were deemed to be complex pathway
patients. Simple pathway patients who had positive diag-
nosis obtained at first bronchoscopy were compared with
those who had negative bronchoscopy.
Results
There were 247 new lung cancer patients, of which 133
(54%) were GP referrals and 114(46%) were non-GP
referrals. The latter group consisted of 69 casualty and 45
internal referrals. There were 159 male and 88 female
patients with median age of 71 years (range 31–89 years).
Histological diagnoses were obtained in 204 (82.6%)
patients, which consisted of small cell (SCLC) in 33
(13.3%), non-small cell (NSCLC) in 170 (69%) and
mixed in 1 patient (0.004%). TNM staging was available
for 188 patients who were clinically considered to be
NSCLC including 18 patients without histological confir-
mation who were treated as NSCLC on clinical grounds
alone. The NSCLC patients were staged as I, II, IIIa and
IIIb-IV in 13.8%, 7.9%, 12.8% and 65.4% respectively.
Formal staging was not applied to 26 unfit patients (Fig-
ure 1).
The overall treatment modalities used were surgery, chem-
otherapy and radiotherapy in 17.4%, 36.8% and 17.4%
respectively. The remaining 28.4% did not receive any
treatment because of patient choice or poor condition.
Out of 33 SCLC patients 24 received chemotherapy and 2
received radiotherapy. Of the remaining 7 SCLC patients,
5 died and 2 declined treatment. Similarly among NSCLC
patients 43, 65, and 27 patients received surgery, chemo-
therapy and radiotherapy respectively while 35 received
no treatment (Table 1).
Median intervals in days (inter quartile range) for urgent
GP referral to chest out patient assessment and first defin-
itive treatment were 1 (0–5) and 60 (44–85) respectively
(figures 2 &3). Patients spent a median of 16.5, 25 and 43
days from the time of specialist referral waiting for chem-
otherapy, surgery and radiotherapy to commence.
Out of 133 GP referral patients 130 (98%) had a bron-
choscopy. The first bronchoscopy achieved tissue diagno-
sis in 64 (49%) patients while it was unsuccessful in 55
(51%). GP referral to treatment intervals for the bron-
choscopy positive group was 44 (37–60) days comparedJournal of Cardiothoracic Surgery 2007, 2:5 http://www.cardiothoracicsurgery.org/content/2/1/5
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to 80 (54–107) days for bronchoscopy negative group
which was highly significant (p < 0.01).
Discussion
The adverse impact of prolonged waiting time on the out
come of lung cancer treatment has been well established
[4,5]. Delays in lung cancer treatment can be divided into
pre-hospital delay and hospital delay. Pre-hospital delay
i.e. delay from the onset of symptoms to presentation are
largely dependent on severity of symptoms, level of edu-
cation and complex socio-economic factors that are less
within the control of physicians. This can only be
improved by addressing wider health issues involving
public education, improved awareness and socioeco-
nomic development. There is however scope for improve-
ment in hospital delay i.e. after presentation of the patient
to the physician. The published guidelines aim to decrease
this phase of delay.
Table 1: Histology and treatment methods of lung cancer patients (n = 247).
Histology type Surgery Chemotherapy Radiotherapy No treatment Total
Small cell 0 24 2 7 33
Non-small cell 43 65 27 35 170
No histology 0 2 14 28 44
A l l4 39 14 37 02 4 7
Staging of 188 NSCLC patients and their first methods of treatment Figure 1
Staging of 188 NSCLC patients and their first methods of treatment.
First treatment method and staging
0
20
40
60
80
100
120
140
I II IIIA IIIB/IV
Surgery Chemotherapy XRT None givenJournal of Cardiothoracic Surgery 2007, 2:5 http://www.cardiothoracicsurgery.org/content/2/1/5
Page 4 of 5
(page number not for citation purposes)
This study emphasizes that previously reported delays [6-
8] in treatment of lung cancer persist despite multidisci-
plinary team meetings and the focus on waiting time tar-
gets. Most patients are seen for consultation within the
prescribed target of two weeks. The median interval of 60
days between referral and treatment, however, shows that
the NHS Cancer Plan target is exceeded in 50% cases. Sim-
ilar delays have been reported from European countries
[7,8] as well as Canada [9].
Most of the delay in our patients is attributable to com-
plex patient pathways and the waits for investigations and
initiating treatment. This is most marked in patients who
need multiple investigations for diagnosis, staging or
assessment of fitness, where each delay or repeat MDT dis-
cussion can have a significant cumulative effect [10]. This
is clearly evident from comparison of waiting times
between the patients who had positive tissue diagnosis at
first bronchoscopic biopsy and those whose initial biop-
sies were negative. This reflected the need for multiple
additional investigations in these patients. Only a small
proportion of the delay was found to be due to patient fac-
tors such as not keeping appointments.
The excessive waiting time occurs for all three modalities
of treatment. Limited availability of radiotherapy facilities
and consequently a long waiting for treatment is mainly
responsible for longest waiting time to treatment in this
subgroup. This has been emphasized by previous studies
from other centres as well [5,9]. Surgically treated patients
underwent greater number of diagnostic and staging pro-
cedures including mediastinoscopy as well as additional
workup for assessment of fitness for surgery which
resulted in longer waiting time. Scarcity of trained tho-
racic surgeons and limited theatre time [11] are well
known. Christie Hospital is the sister hospital specializing
in non surgical oncology services, belonging to the same
trust (South Manchester University Trust) but located at a
short distance away. Some of the patients and their docu-
ments had to travel back and forth between the two sites
which also contributed to small fraction of the delay.
In addition to its adverse impact on the outcome, delays
also cause psychological stress on patients and families
[1]. In a recent study 21% of potentially resectable
tumours became incurable while waiting on the waiting
list and there was an increase in cross-sectional tumour
size of up to 373% [5]. This study clearly suggests the cur-
rent excessive waiting times are not acceptable and needs
improving. More concerted effort at integrated multidisci-
plinary diagnosis and treatment clinics are required. We
are in the process of developing guidelines in order to
streamline the process of diagnostic workup and assess-
ment for fitness in high risk complex patients. There
should also be a significant expansion of infrastructure to
meet the prescribed target times.
Box and Whisker plot of urgent GP referral to outpatient intervals (n = 133) Figure 2
Box and Whisker plot of urgent GP referral to outpatient intervals (n = 133). The red line indicates recommended waiting time 
and the whisker represents median. The box shows the inter quartile range from 25th to 75th percentile.Journal of Cardiothoracic Surgery 2007, 2:5 http://www.cardiothoracicsurgery.org/content/2/1/5
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Conclusion
In conclusion this data demonstrates that in our sample
population, current waiting time targets are still not being
achieved in all areas. The majority of patients receive out
patient consultation in the recommended time period.
Subsequently, however there is an excessive wait for the
commencement of all three treatment modalities.
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Box and Whisker plot of urgent GP referral to first mode of treatment (n = 133) Figure 3
Box and Whisker plot of urgent GP referral to first mode of treatment (n = 133). The red line indicates recommended waiting 
time and the whisker represents median. The box shows the inter quartile range from 25th to 75th percentile.